Tekla Capital Management’s Amicus Therapeutics FOLD Stock Holding History

Tekla Capital Management’s Portfolio FOLD Stock Details FOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-587,277	Closed	-$5.61M	–	175
2021 Q3	$5.61M	Sell	587,277 -34,382	-6%	-$352K	0.18%	100
2021 Q2	$5.99M	Hold	621,659	–	–	0.19%	111
2021 Q1	$6.14M	Buy	621,659 +216,033	+53%	+$3.34M	0.21%	105
2020 Q4	$9.37M	Hold	405,626	–	–	0.33%	83
2020 Q3	$5.73M	Buy	405,626 +68,642	+20%	+$1M	0.21%	103
2020 Q2	$5.08M	Sell	336,984 -31,976	-9%	-$390K	0.19%	100
2020 Q1	$3.41M	Hold	368,960	–	–	0.15%	108
2019 Q4	$3.59M	Buy	368,960 +54,363	+17%	+$498K	0.14%	129
2019 Q3	$2.52M	Hold	314,597	–	–	0.11%	124
2019 Q2	$3.93M	Hold	314,597	–	–	0.16%	103
2019 Q1	$4.28M	Sell	314,597 -560,707	-64%	-$6.85M	0.17%	102
2018 Q4	$8.38M	Hold	875,304	–	–	0.36%	59
2018 Q3	$10.6M	Hold	875,304	–	–	0.38%	62
2018 Q2	$13.7M	Hold	875,304	–	–	0.52%	43
2018 Q1	$13.2M	Buy	875,304 +270,384	+45%	+$4.11M	0.51%	45
2017 Q4	$8.71M	Buy	604,920 +329,426	+120%	+$4.53M	0.34%	61
2017 Q3	$4.15M	Buy	275,494 +114,764	+71%	+$1.52M	0.15%	94
2017 Q2	$1.62M	Sell	160,730 -258,000	-62%	-$2.08M	0.06%	118
2017 Q1	$2.99M	Hold	418,730	–	–	0.12%	96
2016 Q4	$2.08M	Buy	418,730 +160,730	+62%	+$1.11M	0.09%	107
2016 Q3	$1.91M	Hold	258,000	–	–	0.07%	118
2016 Q2	$1.41M	Hold	258,000	–	–	0.06%	141
2016 Q1	$2.18M	Buy	+258,000	New	+$1.83M	0.09%	118

Other funds holding FOLD

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Tekla Capital Management's FOLD Position: Q4 2021 in Review

Tekla Capital Management sold out of Amicus Therapeutics (FOLD) in Q4 2021, closing a stake of 587,277 shares — an estimated $5.61M sold.

Tekla Capital Management first reported a position in FOLD in Q1 2016 and held it in 23 quarters. The position peaked at $13.7M in Q2 2018. 224 funds tracked by Wall St. Rank hold FOLD as of Q4 2021.

Tekla Capital Management reported no remaining Amicus Therapeutics position as of Q4 2021 after selling out during the quarter.
Tekla Capital Management sold 587,277 Amicus Therapeutics shares in Q4 2021, an estimated $5.61M.
Tekla Capital Management first reported a position in Amicus Therapeutics in Q1 2016 and held it in 23 quarters.
Tekla Capital Management's Amicus Therapeutics position peaked at $13.7M in Q2 2018.
224 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q4 2021.

Based on Tekla Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.